Emily Hodge Speaking at the Compliance Congress for Specialty Products

Emily Hodge is moderating the panel “Optimize and Mitigate Risk Within Patient Interactions and Support Programs” at the Compliance Congress for Specialty Products on Wednesday, September 28th from 11:30 a.m. - 12:15 p.m.

The panel will discuss the increase in scrutiny around patient services and interactions, and the importance for compliance teams to ensure that plans are in place to reduce risk. In particular, the following will be issues will be covered:

• Highlight the key considerations for specialty pharmaceutical manufacturers when interacting directly with patients
• Navigate the risks and merits of patient support activities and develop strategies for promoting appropriate business engagements with patient advocacy organizations
• Address the idea of developing compliant and educational based physician programs for those who potentially know less about the specialty disease than their own patient
• How to create a balance between program objectives and compliance

More information can be found here.